# Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab

> **NCT00240578** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 88 (actual)

## Conditions studied

- Lymphoma, Non-Hodgkin

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00240578
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2016-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00240578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00240578, "Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00240578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*